Package 71610-034-65

{"route": ["ORAL"], "spl_id": "d18746db-ee0c-4e00-b4b1-dfd10e32d1b3", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "unii": ["R16CO5Y76E"], "rxcui": ["198467"], "spl_set_id": ["49f46b08-b2fe-4e4d-b235-983dab9740cc"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (71610-034-65)", "package_ndc": "71610-034-65", "marketing_start_date": "20180126"}], "brand_name": "Aspirin", "product_id": "71610-034_d18746db-ee0c-4e00-b4b1-dfd10e32d1b3", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "71610-034", "generic_name": "Aspirin", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Aspirin", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}], "application_number": "part343", "marketing_category": "OTC MONOGRAPH FINAL", "marketing_start_date": "20150501", "listing_expiration_date": "20261231"}